Developing biomarkers for use in Parkinson’s disease

Tony Vernon, Kings College London

Research interests: Combining neuroimaging, cellular and post-mortem approaches to better understand the lack of continuity between the levels of analysis used in animal models and clinical research in psychopharmacology.

More info: https://kclpure.kcl.ac.uk/portal/anthony.vernon.html